Life Care News

A Hope Of True Information

Copyright © 2015 - 2022 Lifecarenews.in

LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283

KemPharm Receives FDA Orphan Drug Designation for Serdexmethylphenidate (SDX) for the Treatment of Idiopathic Hypersomnia (IH)

By Globe News Wire On Nov 20, 2022

Phase 2 clinical trial investigating KP1077 in patients with IH expected to initiate prior to year-end 2022

Designation Drug FDA Hypersomnia Idiopathic

Get real time updates directly on you device, subscribe now.

Globe News Wire

Prev Post

Best Black Friday Treadmill Deals (2022): Best Early Home, Commercial, Smart, Folding & More Treadmill Sales Rounded Up by Consumer Articles

Next Post

The Best Rowing Machine Black Friday Deals 2022: Top Early Air, Hydraulic, Magnetic & Water Rower Savings Shared by Deal Tomato